About Us
Our Mission
Company Profile
Executive Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
ProTcell platform
Pipeline
FAQ
News & Resources
Press releases
Smart Stories
Partnering
Contact
Press Releases
All
Smart Stories
All
Press Releases
All
Factsheets
Smart Immune Doses First Leukemia Patients with ProTcell Therapy SMART101 in ReSET-02 Phase I/II Trial
September 27, 2023
Smart Immune announces participation in leading scientific conferences
August 1, 2023
PRO-THYMUS: a groundbreaking solution to restore the immune system in AML patients, laureate of the Eurostars 3 program
July 11, 2023
Smart Immune to present details of the phase I/II studies of new T-cell therapy SMART101 at the European Hematology Association (EHA)
May 11, 2023
Smart Immune receives $5 million investment to further its thymus-empowered ProTcell therapy platform
April 17, 2023
Smart Immune receives €2.5m grant and €15m equity investment commitment from the European Innovation Council (EIC) via the EIC Accelerator
March 30, 2023
Next
→